Text and Data Mining valid from 2019-06-07
First Online: 7 June 2019
Compliance with Ethical Standards
: This study was approved by the Partners Institutional Review Board Human Studies Committee.
: The authors declare that they have no conflict of interest. There are no financial relationships deemed relevant to this manuscript for either author. Dr. Schmahmann receives consulting fees from Cadent pharmaceuticals and grant support from the National Ataxia Foundation and the Ataxia Telangiectasia Children’s Project. Dr. Schmahmann received financial support from Biohaven and Dr. Stephen received financial support from Biohaven, Sanofi/Genzyme, Bristol-Myers Squibb and Biogen for the conduct of clinical trials.